Case Details

Year Initiated/Committed

2006

Year Resolved

2006

Settlement Amount

$14 million

Court

U.S. District Court for the Eastern District of Pennsylvania

Docket Number

2:06-cv-01298-JP

Lead State

MD, MI, NY, WI

Participating States

AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WY

Defendant(s)

SmithKline Beecham Corp.; SmithKline Beecham PLC

Case Description

States alleged that SmithKline Beecham, manufacturer of the anti-depressant Paxil, had filed patents for allegedly different fomulas of essentially the same product. The states alleged that the defendant filed a series of meritless infringement lawsuits against generic manufacturers. Generic entry was prevented for six years. The states settled their proprietary claims for $14 million. Two previous setlements totalling $165 million covered consumers and pharmacy purchasers.